ARID1A and familial pancreatic carcinoma: ARID1A nonsense/missense mutations have been reported in tumors from patients with pancreatic cancer [40,41], and an in vitro or in vivo loss of ARID1A expression in the pancreas is associated with reduced SOX9 expression and cancer cell differentiation [42].